Deep knowledge on
small-molecule drugs and
the 90,000 global patents
covering them

Start your free trial now

Instant access. No credit card. No commitment.

Plans and Pricing

DrugPatentWatch Ultimate Plan Preview

Profile for Tradename: COMBIPATCH

« Back to Dashboard
Combipatch is a drug marketed by Noven Pharms Inc and is included in one NDA. It is available from two suppliers. There is one patent protecting this drug.

This drug has one hundred and fifty patent family members in twenty-eight countries.

The generic ingredient in COMBIPATCH is estradiol; norethindrone acetate. There are seventy-four drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the estradiol; norethindrone acetate profile page.

Summary for Tradename: COMBIPATCH

Patents:1
Applicants:1
NDAs:1
Suppliers: see list2
Formulation / Manufacturing:see details

Pharmacology for Tradename: COMBIPATCH

Clinical Trials for: COMBIPATCH

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Noven Pharms Inc
COMBIPATCH
estradiol; norethindrone acetate
FILM, EXTENDED RELEASE;TRANSDERMAL020870-001Aug 7, 1998RXNo5,656,286<disabled><disabled>
Noven Pharms Inc
COMBIPATCH
estradiol; norethindrone acetate
FILM, EXTENDED RELEASE;TRANSDERMAL020870-002Aug 7, 1998RXYes5,656,286<disabled><disabled>
This preview shows a limited data set
Subscribe for full access, or try a free trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Tradename: COMBIPATCH

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
5,332,576 Compositions and methods for topical administration of pharmaceutically active agents<disabled in preview>
4,994,278 Breathable backing<disabled in preview>
4,814,168 Transdermal multipolymer drug delivery system<disabled in preview>
6,235,306 Solubility parameter based drug delivery system and method for altering drug saturation concentration<disabled in preview>
6,221,383 Solubility parameter based drug delivery system and method for altering drug saturation concentration<disabled in preview>
This preview shows a limited data set
Subscribe for full access, or try a free trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Tradename: COMBIPATCH

Country Document Number Publication Date
Germany69029909Sep 11, 1997
Singapore43349Oct 17, 1997
World Intellectual Property Organization (WIPO)9640086Dec 19, 1996
Mexico9203648Jan 31, 1995
Mexico9602656Jun 28, 1998
This preview shows a limited data set
Subscribe for full access, or try a free trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

DrugPatentWatch Archives

You are viewing the current data set
Select a link below to view the archives:

 2000   2001   2002   2003   2004   2005   2006   2007   2008   2009   2010   2011   2012   2013   2014  

For more information try a free trial or see the plan comparison

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2015 thinkBiotech LLC
ISSN: 2162-2639

Preferred citation:

Friedman, Y. Location of pharmaceutical innovation: 2000–2009 Nature Reviews Drug Discovery 9, 835–836 (2010).

Connect with Social Media:

Follow DrugPatentWatch on Twitter
Connect with DrugPatentWatch on Linkedin
Drug Patents on LinkedIn
`abc